Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol

Peer Review reports

Original Submission
23 Jan 2023	Submitted	Original manuscript
25 Apr 2023	Author responded	Author comments - Yasmin A. Civil
Resubmission - Version 2
25 Apr 2023	Submitted	Manuscript version 2
Publishing
3 May 2023	Editorially accepted
9 May 2023	Article published	10.1186/s12885-023-10910-6

Back to article page